MET and neoplasm: Our data suggested that EpEX and HGFR coordinately stimulate downstream HGFR signaling to promote tumor progression and cell invasion, so we wanted to further test the anti-tumor effects of simultaneously blocking both EpCAM and HGFR signaling.